[Federal Register Volume 69, Number 65 (Monday, April 5, 2004)]
[Proposed Rules]
[Pages 17615-17616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-7714]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

21 CFR Chapter I

[Docket No. 2004N-0115]


Prescription Drug Importation; Public Meeting and Establishment 
of Docket; Extension of Deadline for Speakers To Submit Requests for 
Presentations

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting and establishment of docket; extension 
of deadline to submit requests for presentations.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending to April 
6, 2004, the deadline for speakers to submit requests for presentations 
and a summary of the presentation at the April 14, 2004, public meeting 
on prescription drug importation. This public meeting was announced in 
the

[[Page 17616]]

Federal Register of March 18, 2004 (69 FR 12810).

DATES: Written requests for presentations and summaries of the 
presentations must be submitted by April 6, 2004.

ADDRESSES: Submit a request for presentations and a summary of your 
presentation to Karen Strambler, Office of Policy, Office of the 
Commissioner, Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-3360, e-mail: [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of March 18, 2004 
(69 FR 12810), FDA published a notice of public meeting and 
establishment of docket announcing that it established a docket to 
receive information and comments on certain issues related to the 
importation of prescription drugs. FDA also announced a public meeting 
to enable interested individuals, organizations, and other stakeholders 
to present information to the Task Force for consideration in the study 
on importation mandated by the Medicare Prescription Drug, Improvement 
and Modernization Act of 2003. Speakers were asked to submit requests 
for presentations along with a short summary of their presentation by 
close of business on March 30, 2004. FDA is extending that deadline to 
April 6, 2004.
    All other information and requirements of the March 18, 2004, 
Federal Register notice remain the same.

    Dated: March 31, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-7714 Filed 4-1-04; 11:04 am]
BILLING CODE 4160-01-S